Abstract
The outbreak of the Covid-19 pandemic, caused by the SARS-CoV-2 virus from the coronavirus family responsible for SARS and MERS, originated in Wuhan and quickly spread globally. International collaboration has been pivotal in the fight to achieve endemic control. Every nation has strived to acquire Covid-19 vaccines to safeguard their populations. For example, Indonesia forged a bilateral partnership with Japan to secure Covid-19 vaccines. Japan holds a strategic position as one of Indonesia's top five investors. Throughout the pandemic, the Indonesian Ministry of Foreign Affairs maintained close communication with its Japanese counterpart to request support in obtaining the Covid-19 vaccine. This collaboration was made possible by Indonesia's independent and proactive foreign policy, which created extensive opportunities for cooperation during the pandemic. This study aims to present the outcomes of the Indonesia-Japan collaboration in procuring Covid-19 vaccines for Indonesia, showcasing the implementation of an independent and proactive foreign policy that can yield substantial benefits.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
